↓ Skip to main content

Cochrane Database of Systematic Reviews

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease

Overview of attention for article published in this source, April 2013
Altmetric Badge

Mentioned by

policy
1 policy source
patent
1 patent
facebook
2 Facebook pages

Citations

dimensions_citation
116 Dimensions

Readers on

mendeley
123 Mendeley
Title
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Published by
John Wiley & Sons, Ltd, April 2013
DOI 10.1002/14651858.cd000545.pub4
Pubmed ID
Authors

Chande, Nilesh, Tsoulis, David J, MacDonald, John K

Abstract

The results from controlled clinical trials investigating the efficacy of azathioprine and 6-mercaptopurine for the treatment of active Crohn's disease have been conflicting and controversial. An updated meta-analysis was performed to assess the effectiveness of these drugs for the induction of remission in active Crohn's disease.

Mendeley readers

The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 4 3%
Chile 1 <1%
Ireland 1 <1%
Norway 1 <1%
Italy 1 <1%
United States 1 <1%
Unknown 114 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 17%
Other 16 13%
Student > Ph. D. Student 16 13%
Student > Bachelor 14 11%
Student > Master 12 10%
Other 32 26%
Unknown 12 10%
Readers by discipline Count As %
Medicine and Dentistry 73 59%
Agricultural and Biological Sciences 7 6%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Computer Science 3 2%
Economics, Econometrics and Finance 3 2%
Other 15 12%
Unknown 15 12%